| Grafton Oaks Nursing And Rehabilitation Center | |
| 405 Grafton Avenue, Dayton, Ohio 45406 | |
| (937) 276-4040 | |
| Name | Grafton Oaks Nursing And Rehabilitation Center |
|---|---|
| Location | 405 Grafton Avenue, Dayton, Ohio |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 99 |
| Occupancy Rate | 64.34% |
| Medicare ID (CCN) | 365716 |
| Legal Business Name | Grafton Associates Limited Partnership Ptr |
| Ownership Type | For Profit - Partnership |
| NPI Number | 1083656383 |
| Organization Name | GRAFTON ASSOCIATES LIMITED PARTNERSHIP PTR |
| Address | 405 Grafton Avenue, Dayton, OH 45406 |
| Phone Number | 937-276-4040 |
News Archive
Colorectal cancer is fairly treatable when caught early with regular screenings, but it is still the second-leading cause of cancer-related deaths in American men and the third-leading cause in women.
Kaiser Permanente, the largest integrated health system in the nation, led the development of a neonatal sepsis risk calculator that has safely reduced antibiotic use by nearly 50 percent in newborns, according to research published today in JAMA Pediatrics.
While studies have shown that diabetes education programs are crucial in helping individuals living with the disease self-manage their condition, a new study led by Ryerson researchers has found that less than half of primary-care physicians surveyed refer all of their patients with diabetes to these programs.
Receptos, Inc., a privately held biopharmaceutical company, announced the closing of a two-tranche $25 million Series A financing. The company is focused on identifying and developing best- and first-in-class GPCR therapeutic candidates through information-driven drug discovery, including GPCR structure. Investors include ARCH Venture Partners, Flagship Ventures, Lilly Ventures and Venrock.
Scientists from the Spanish National Cancer Research Centre have discovered a new strategy to fight cancer, which is very different from those described to date. Their work shows for the first time that telomeres - the structures protecting the ends of the chromosomes - may represent an effective anti-cancer target: by blocking the TRF1 gene, which is essential for the telomeres, they have shown dramatic improvements in mice with lung cancer.
› Verified 4 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Colorectal cancer is fairly treatable when caught early with regular screenings, but it is still the second-leading cause of cancer-related deaths in American men and the third-leading cause in women.
Kaiser Permanente, the largest integrated health system in the nation, led the development of a neonatal sepsis risk calculator that has safely reduced antibiotic use by nearly 50 percent in newborns, according to research published today in JAMA Pediatrics.
While studies have shown that diabetes education programs are crucial in helping individuals living with the disease self-manage their condition, a new study led by Ryerson researchers has found that less than half of primary-care physicians surveyed refer all of their patients with diabetes to these programs.
Receptos, Inc., a privately held biopharmaceutical company, announced the closing of a two-tranche $25 million Series A financing. The company is focused on identifying and developing best- and first-in-class GPCR therapeutic candidates through information-driven drug discovery, including GPCR structure. Investors include ARCH Venture Partners, Flagship Ventures, Lilly Ventures and Venrock.
Scientists from the Spanish National Cancer Research Centre have discovered a new strategy to fight cancer, which is very different from those described to date. Their work shows for the first time that telomeres - the structures protecting the ends of the chromosomes - may represent an effective anti-cancer target: by blocking the TRF1 gene, which is essential for the telomeres, they have shown dramatic improvements in mice with lung cancer.
› Verified 4 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $66633 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 13.48 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 3.52 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 33.14 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.37 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.03 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 51.06 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 0.33 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.67 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 23.2 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 97.26 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.63 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 18.99 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 29.1 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 2.13 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.77 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 75.39 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 93.67 | 82.93 |
News Archive
Colorectal cancer is fairly treatable when caught early with regular screenings, but it is still the second-leading cause of cancer-related deaths in American men and the third-leading cause in women.
Kaiser Permanente, the largest integrated health system in the nation, led the development of a neonatal sepsis risk calculator that has safely reduced antibiotic use by nearly 50 percent in newborns, according to research published today in JAMA Pediatrics.
While studies have shown that diabetes education programs are crucial in helping individuals living with the disease self-manage their condition, a new study led by Ryerson researchers has found that less than half of primary-care physicians surveyed refer all of their patients with diabetes to these programs.
Receptos, Inc., a privately held biopharmaceutical company, announced the closing of a two-tranche $25 million Series A financing. The company is focused on identifying and developing best- and first-in-class GPCR therapeutic candidates through information-driven drug discovery, including GPCR structure. Investors include ARCH Venture Partners, Flagship Ventures, Lilly Ventures and Venrock.
Scientists from the Spanish National Cancer Research Centre have discovered a new strategy to fight cancer, which is very different from those described to date. Their work shows for the first time that telomeres - the structures protecting the ends of the chromosomes - may represent an effective anti-cancer target: by blocking the TRF1 gene, which is essential for the telomeres, they have shown dramatic improvements in mice with lung cancer.
› Verified 4 days ago
Garden Court Nursing And Rehabilitation Center Location: 4911 Covenant House Drive, Dayton, Ohio 45426 Phone: (937) 837-2651 | |
Promedica Skilled Nursing And Rehab Beavercreek Location: 1974 North Fairfield Road, Dayton, Ohio 45432 Phone: (937) 429-1106 | |